Anavex Life Sciences (AVXL) Short Interest Ratio & Short Volume $7.53 -0.91 (-10.78%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Anavex Life Sciences Short Interest DataAnavex Life Sciences (AVXL) has a short interest of 23.49 million shares. This marks a -2.17% decrease in short interest from the previous month. The short interest ratio (days to cover) is 23.3, indicating that it would take 23.3 days of the average trading volume of 1.22 million shares to cover all short positions.Current Short Interest23,490,000 sharesPrevious Short Interest24,010,000 sharesChange Vs. Previous Month-2.17%Dollar Volume Sold Short$223.16 millionShort Interest Ratio23.3 Days to CoverLast Record DateApril 30, 2025Outstanding Shares85,372,000 sharesPercentage of Shares Shorted27.51%Today's Trading Volume3,117,161 sharesAverage Trading Volume1,222,856 sharesToday's Volume Vs. Average255% Short Selling Anavex Life Sciences? Sign up to receive the latest short interest report for Anavex Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAVXL Short Interest Over TimeAVXL Days to Cover Over TimeAVXL Percentage of Float Shorted Over Time Anavex Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202523,490,000 shares $223.16 million -2.2%N/A23.3 $9.50 4/15/202524,010,000 shares $218.97 million -2.4%31.7%22.7 $9.12 3/31/202524,590,000 shares $210.98 million +2.3%32.5%18.8 $8.58 3/15/202524,040,000 shares $226.70 million +2.6%31.8%14.9 $9.43 2/28/202523,440,000 shares $185.41 million -3.1%31.0%14.2 $7.91 2/15/202524,200,000 shares $206.18 million +3.3%32.0%14.2 $8.52 1/31/202523,430,000 shares $217.20 million +0.1%N/A12.9 $9.27 1/15/202523,400,000 shares $265.12 million +7.3%N/A12.3 $11.33 12/31/202421,800,000 shares $234.13 million +4.7%N/A12.7 $10.74 12/15/202420,820,000 shares $176.14 million +5.7%N/A15.8 $8.46 Get the Latest News and Ratings for AVXL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anavex Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 11/30/202419,690,000 shares $186.27 million +4.7%N/A17.3 $9.46 11/15/202418,810,000 shares $140.04 million +2.7%N/A18.1 $7.45 10/31/202418,310,000 shares $121.21 million +2.2%N/A21.1 $6.62 10/15/202417,910,000 shares $96.53 million +1.8%N/A22.7 $5.39 9/30/202417,590,000 shares $99.91 million -10.3%N/A19.5 $5.68 9/15/202419,610,000 shares $104.13 million +1.1%N/A20.1 $5.31 8/31/202419,390,000 shares $116.73 million -1.8%N/A17.8 $6.02 8/15/202419,750,000 shares $124.62 million -0.7%N/A17.2 $6.31 7/31/202419,880,000 shares $135.08 million +7.8%N/A16.3 $6.80 7/15/202418,440,000 shares $107.51 million +3.4%N/A15.8 $5.83 6/30/202417,830,000 shares $75.24 million -14.9%N/A15.4 $4.22 6/15/202420,940,000 shares $78.94 million -4.0%N/A17.6 $3.77 5/31/202421,820,000 shares $88.59 million -0.2%N/A17.6 $4.06 5/15/202421,860,000 shares $98.15 million +2.7%N/A17.5 $4.49 4/30/202421,290,000 shares $77.71 million -3.3%N/A16.6 $3.65 4/15/202422,010,000 shares $93.10 million -0.5%N/A17.1 $4.23 3/31/202422,120,000 shares $112.59 million +10.6%N/A17.3 $5.09 3/15/202420,000,000 shares $102.20 million -0.1%N/A13.4 $5.11 2/29/202420,020,000 shares $102.90 million +0.7%N/A13.9 $5.14 2/15/202419,890,000 shares $115.96 million -1.2%N/A13.7 $5.83 1/31/202420,130,000 shares $120.18 million -2.6%N/A13.9 $5.97 1/15/202420,660,000 shares $123.75 million +2.9%N/A14.4 $5.99 12/31/202320,070,000 shares $186.85 million +10.8%N/A14.8 $9.31 12/15/202318,120,000 shares $160.18 million +0.8%N/A16.6 $8.84 11/30/202317,970,000 shares $129.56 million -0.8%N/A17.6 $7.21 11/15/202318,120,000 shares $111.98 million -2.6%N/A18.8 $6.18 10/31/202318,610,000 shares $103.84 million +4.5%N/A20.3 $5.58 10/15/202317,810,000 shares $107.75 million -0.9%N/A20.5 $6.05 9/30/202317,970,000 shares $117.70 million +5.2%N/A21.8 $6.55 9/15/202317,090,000 shares $129.37 million +1.2%N/A20.4 $7.57Trump’s Bitcoin Reserve is No Accident… (Ad)Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…Just click here to get all the details on this crypto coin now 8/31/202316,880,000 shares $133.35 million +1.0%N/A19.3 $7.90 8/15/202316,720,000 shares $149.48 million +1.1%N/A18.5 $8.94 7/31/202316,540,000 shares $136.46 million -1.1%N/A18.1 $8.25 7/15/202316,730,000 shares $140.87 million -0.1%N/A18.8 $8.42 6/30/202316,740,000 shares $136.10 million -5.6%N/A17.8 $8.13 6/15/202317,740,000 shares $156.64 million +7.5%N/A17.9 $8.83 5/31/202316,510,000 shares $152.55 million +3.8%N/A15.9 $9.24 5/15/202315,900,000 shares $150.89 million +10.6%N/A15.9 $9.49 4/30/202314,380,000 shares $117.05 million -7.8%N/A13.7 $8.14 4/15/202315,590,000 shares $122.85 million -1.9%N/A14.4 $7.88 3/31/202315,890,000 shares $136.18 million +1.3%N/A13.8 $8.57 3/15/202315,680,000 shares $146.76 million -3.9%N/A13.2 $9.36 2/28/202316,320,000 shares $155.37 million -4.7%N/A7.5 $9.52 2/15/202317,130,000 shares $179.35 million +2.5%N/A7.4 $10.47 1/31/202316,720,000 shares $181.75 million -9.0%N/A7.1 $10.87 1/15/202318,370,000 shares $194.35 million +0.7%N/A8.1 $10.58 12/30/202218,250,000 shares $169.00 million +15.7%N/A8.2 $9.26 12/15/202215,780,000 shares $131.76 million +32.5%N/A7.3 $8.35 11/30/202211,910,000 shares $105.05 million +17.1%N/A6 $8.82 11/15/202210,170,000 shares $142.89 million +0.6%N/A11.6 $14.05 10/31/202210,110,000 shares $123.04 million +0.7%N/A12.7 $12.17 10/15/202210,040,000 shares $106.42 million -2.1%N/A12.5 $10.60 9/30/202210,260,000 shares $105.88 million +5.3%N/A13 $10.32 9/15/20229,740,000 shares $92.63 million +7.0%N/A12.1 $9.51 8/31/20229,100,000 shares $87.27 million +8.0%N/A10.6 $9.59 8/15/20228,430,000 shares $100.06 million -3.4%N/A9.6 $11.87 7/31/20228,730,000 shares $89.57 million +5.7%N/A9.3 $10.26 7/15/20228,260,000 shares $104.90 million -5.2%N/A8.8 $12.70 6/30/20228,710,000 shares $87.19 million -8.3%N/A9.7 $10.01 6/15/20229,500,000 shares $76.95 million +6.6%N/A10.6 $8.10 5/31/20228,910,000 shares $81.17 million +1.5%N/A10.1 $9.11 5/15/20228,780,000 shares $75.42 million +8.0%N/A9.4 $8.59 4/30/20228,130,000 shares $69.84 million +3.2%N/A8.5 $8.59 4/15/20227,880,000 shares $87.47 million +3.6%N/A6.9 $11.10 3/31/20227,610,000 shares $93.68 million -5.4%N/A6.3 $12.31 3/15/20228,040,000 shares $85.63 million +2.4%N/A6.6 $10.65 2/28/20227,850,000 shares $86.04 million No ChangeN/A6.6 $10.96 2/15/20227,850,000 shares $99.85 million +34.0%N/A6.4 $12.72 1/31/20225,860,000 shares $76.65 million +21.1%N/A5.1 $13.08 1/15/20224,840,000 shares $69.65 million +7.6%N/A5.2 $14.39 12/31/20214,500,000 shares $78.03 million -6.8%N/A5.3 $17.34 12/15/20214,830,000 shares $92.45 million +0.4%N/A5.8 $19.14 11/30/20214,810,000 shares $93.31 million +9.1%N/A5.9 $19.40 11/15/20214,410,000 shares $94.82 million -14.0%9.9%5.5 $21.50 10/29/20215,130,000 shares $96.14 million +0.4%11.5%6.1 $18.74 10/15/20215,110,000 shares $89.53 million -12.2%11.5%5.3 $17.52 9/30/20215,820,000 shares $104.47 million +3.4%13.1%4.8 $17.95 9/15/20215,630,000 shares $96.10 million -5.5%N/A3.2 $17.07 8/31/20215,960,000 shares $116.16 million -14.1%N/A2.3 $19.49 8/13/20216,940,000 shares $135.68 million +3.7%N/A2.6 $19.55Warning: Prepare to Be Shocked by These Payouts (Ad)There's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don't even pay dividends. It's fast, it's legal, and most people have no clue it exists.Click here to see how much you could be collecting each month → 7/30/20216,690,000 shares $120.09 million -12.0%N/A2.5 $17.95 7/15/20217,600,000 shares $168.42 million -13.3%N/A3.1 $22.16 6/30/20218,770,000 shares $200.48 million +24.9%12.5%3.7 $22.86 6/15/20217,020,000 shares $121.73 million +7.3%10.4%3.8 $17.34 5/28/20216,540,000 shares $81.42 million -0.3%9.7%5.7 $12.45 5/14/20216,560,000 shares $66.65 million -4.9%N/A5 $10.16 4/30/20216,900,000 shares $84.53 million +8.0%N/A4.2 $12.25 4/15/20216,390,000 shares $82.24 million +13.9%N/A1.6 $12.87 3/31/20215,610,000 shares $78.71 million +55.8%N/A1.4 $14.03 3/15/20213,600,000 shares $50.51 million -9.1%N/A0.9 $14.03 2/26/20213,960,000 shares $51.72 million -1.3%N/A1 $13.06 2/12/20214,010,000 shares $50.95 million -23.8%N/A1.1 $12.71 1/29/20215,260,000 shares $33.35 million -5.7%N/A1.4 $6.34 1/15/20215,580,000 shares $33.03 million -0.7%N/A4.3 $5.92 12/31/20205,620,000 shares $30.85 million -16.4%N/A3.7 $5.49 12/15/20206,720,000 shares $34.88 million -9.6%N/A4.5 $5.19 11/30/20207,430,000 shares $39.90 million -3.9%N/A6 $5.37 11/15/20207,730,000 shares $41.59 million +17.3%N/A6.6 $5.38 10/30/20206,590,000 shares $39.41 million -6.9%N/A5.9 $5.98 10/15/20207,080,000 shares $30.73 million -3.7%N/A7.6 $4.34 9/30/20207,350,000 shares $33.44 million -4.2%N/A11.5 $4.55 9/15/20207,670,000 shares $30.83 million +6.5%N/A12 $4.02 8/31/20207,200,000 shares $30.53 million -3.4%N/A9.8 $4.24 8/14/20207,450,000 shares $31.22 million +23.1%N/A9.9 $4.19 7/31/20206,050,000 shares $25.53 million -12.3%N/A7.6 $4.22 7/15/20206,900,000 shares $31.33 million +8.0%N/A9.4 $4.54 6/30/20206,390,000 shares $31.44 million +5.1%N/A8.8 $4.92 6/15/20206,080,000 shares $24.81 million -6.0%N/A8.1 $4.08 5/29/20206,470,000 shares $26.59 million -11.5%N/A8.3 $4.11 AVXL Short Interest - Frequently Asked Questions What is Anavex Life Sciences' current short interest? Short interest is the volume of Anavex Life Sciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 23,490,000 shares of AVXL short. Learn More on Anavex Life Sciences' current short interest. What is a good short interest ratio for Anavex Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVXL shares currently have a short interest ratio of 23.0. Learn More on Anavex Life Sciences's short interest ratio. Which institutional investors are shorting Anavex Life Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Anavex Life Sciences: Sculptor Capital LP, Walleye Trading LLC, Walleye Capital LLC, Simplex Trading LLC, and National Bank of Canada FI. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Anavex Life Sciences' short interest increasing or decreasing? Anavex Life Sciences saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 23,490,000 shares, a decrease of 2.2% from the previous total of 24,010,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Anavex Life Sciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Anavex Life Sciences: Catalyst Pharmaceuticals, Inc. (6.57%), Protagonist Therapeutics, Inc. (9.87%), Xenon Pharmaceuticals Inc. (4.67%), MoonLake Immunotherapeutics (11.52%), Immunovant, Inc. (30.43%), HUTCHMED (China) Limited (0.24%), Amneal Pharmaceuticals, Inc. (4.44%), Organon & Co. (7.61%), Mirum Pharmaceuticals, Inc. (12.58%), Apellis Pharmaceuticals, Inc. (22.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Anavex Life Sciences stock? Short selling AVXL is an investing strategy that aims to generate trading profit from Anavex Life Sciences as its price is falling. AVXL shares are trading down $0.78 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Anavex Life Sciences? A short squeeze for Anavex Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AVXL, which in turn drives the price of the stock up even further. How often is Anavex Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVXL, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies CPRX Short Interest Data PTGX Short Interest Data XENE Short Interest Data MLTX Short Interest Data IMVT Short Interest Data HCM Short Interest Data AMRX Short Interest Data OGN Short Interest Data MIRM Short Interest Data APLS Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVXL) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersWashington Is Broke—and Eyeing Your Savings NextWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredAI Firm Enters America's Largest Medicaid MarketNew York's $95B system just approved a new AI healthcare platform. Here's what to know. A major shift in U....i2i Marketing Group, LLC | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | Sponsored“Buy” Alert! This stock could soar by July 31stTHREE companies in particular are leading the charge during this exciting time. Here’s why I’m so excited a...Traders Agency | SponsoredTrump’s treachery A shocking bill has been put before the House of Representatives… Representative Brandon Gill wants Preside...Porter & Company | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anavex Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anavex Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.